Search Bar & Filters
Found 2 Actively Recruiting clinical trials
Actively Recruiting
Researchers are studying hysterectomy methods for women with large benign uteruses, a common gynecological surgery in France. The study compares two minimally invasive surgical approaches the traditional laparoscopic hysterectomy and a newer technique called vNOTES Vaginal Natural Orifice Transluminal Endoscopy System. The study aims to determine which method results in fewer complications, as current data do not clearly favor one approach over the other for large uteri. Participants will undergo either a laparoscopic hysterectomy, performed with or without a surgical robot using a standardized method, or a hysterectomy via the vaginal route using the vNOTES system. The vNOTES procedure allows endoscopic surgery through the vagina, offering clear visualization without external scarring. The study is randomized and compares these two surgical techniques specifically for large uteri, focusing on postoperative outcomes. During the trial, participants will be monitored from surgery until six weeks afterward to assess complications and any need to convert from one surgical method to another during the procedure. Researchers will collect data on postoperative pain, complications, and hospitalization time. The study is sponsored by the Centre Hospitalier Universitaire de Saint Etienne and lasts until December 2026, with primary outcome evaluation completed by October 2026.
Actively Recruiting
Crohns disease CD is a chronic inflammatory bowel disease that can severely impact patients quality of life by causing intestinal damage such as stenosis and fistulas, often leading to surgery. The goal of treatment has evolved from just clinical remission to achieving both clinical remission and healing of the intestinal lining, which reduces disease progression risks. The CALM strategy uses close monitoring of symptoms and biological markers like fecal calprotectin to guide treatment intensification and improve healing outcomes. Researchers are investigating whether adding MRI-based assessment of transmural healing to this approach can further reduce disease progression in patients receiving biotherapy. This randomized, open-label study compares two treatment strategies for adults with active Crohns disease starting biotherapy. One group follows the CALM strategy with regular clinical and biological monitoring, while the other group adds scheduled MRI evaluations to assess transmural healing. MRIs are performed at baseline, weeks 24, 52, 76, and 152 in the MRI group, with treatment intensification based on residual activity seen on imaging. Both groups receive biotherapy guided by French consensus guidelines, and patients are followed for approximately three years. Participants will be regularly monitored through clinical evaluations, fecal calprotectin tests, and MRIs as scheduled. They will keep a symptom diary recording abdominal pain and stool frequency monthly. Researchers will measure the proportion of time spent in clinical remission without corticosteroids between weeks 24 and 76 as the primary outcome. Safety and other secondary outcomes will be assessed centrally. The study will analyze data on an intention-to-treat basis and includes ongoing follow-up over nearly three years.